Delta+ variant
Covaxin Shows Overall Efficacy Of 77.8% Against Symptomatic COVID-19 Cases
How Effective Are COVID-19 Vaccines Against Delta Variant? What Data Says
Will The New COVID-19 Variant "Delta Plus" Propel India's Third Wave? 10 Things We Know
/shethepeople/media/agency_attachments/2024/11/11/2024-11-11t082606806z-shethepeople-black-logo-2000-x-2000-px-1.png)
/shethepeople/media/post_banners/EIvzlmicEz3MsZO8SbhQ.jpg)
/shethepeople/media/post_banners/l3JuqAvDefpnqeKtjkum.jpg)
/shethepeople/media/post_banners/fDugs4pJMSKbQqkyCs8p.jpg)
/shethepeople/media/post_banners/xSfkIiqVcmLqZffgtljT.jpg)
/shethepeople/media/media_files/J1SQZ6RXP5IN0mZk4Wzi.png)
/shethepeople/media/post_banners/rnoYu94JxEPYaLnxVori.jpg)
/shethepeople/media/post_banners/2n8P9GGclThZ30frkElF.jpg)
